| 规格 | 10ug |
|---|---|
| 表达宿主 | E.coli |
| 标签 | NA |
| 分子量 | 18.1 KDa |
|---|---|
| 表观分子量 | 18 KDa, reducing conditions |
| 形态 | Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
| 纯度 | Greater than 95% as determined by reducing SDS-PAGE. |
| 内毒素水平 | Less than 0.001 ng/µg (0.01 EU/µg) as determined by LAL test. |
|---|---|
| 活性 | Immobilized Mouse ST2-His(Cat#CK89) at 5μg/ml (100 μl/well) can bind Human IL-33(Cat#C091).The ED50 of Human IL-33(Cat#C091) is 0.63 ug/ml. |
| 溶解方法 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
|---|---|
| 储存方法 | Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks. Reconstituted protein solution can be stored at 4-7°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months. |
| 运输条件 | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature listed below. |
| 背景说明 | Interleukin-33 (IL-33) was initially discovered as a nuclear factor NF-HEV abundantly expressed in high endothelial venules. It is a 30-32 kD pro-inflammatory protein with intracellular and extracellular activities and a chromatin-associated cytokine of the IL-1 family with high sequence and structural similarity to IL-1 and IL-18. IL-33 is highly and selectively expressed by high endothelial venule endothelial cells (HEVECs) in human tonsils, Peyers's patches, and lymph nodes. It contains a bipartite nuclear localization signal at the C-terminus, and is targeted to the nucleus when ectopically expressed in human umbilical vein endothelial cells (HUVECs) and HeLa cells. The C-terminal fragment, corresponding to mature IL-33, binds and triggers signaling. IL-33 mediates its biological effects via Toll-interleukin 1 (IL-1) receptor (TIR) domain-containing receptor ST2, activates NF-kappaB and MAP kinases, and drives production of T(H)2-associated cytokines from in vitro polarized T(H)2 cells. In vivo, IL-33 induces the expression of IL-4, IL-5, and IL-13 and leads to severe pathological changes in mucosal organs. Human IL-33 is 270 amino acids in length. |
|---|
| 产品名称 | 点击数 |
|---|---|
| 地克珠利-BSA(或OVA)抗原 | 3802 |
| 牛血清白蛋白(BSA) | 3972 |
| 赛庚啶-BSA(或OVA)抗原 | 3859 |
| 丙酸睾酮-BSA(或OVA)抗原 | 3950 |
| 三聚氰胺(MEL)-BSA(或OVA)抗原 | 3739 |
| 苯甲酸雌二醇-BSA(或OVA)抗原 | 3842 |
| 红霉素-BSA(或OVA)抗原 | 3853 |
| 喹乙醇代谢物MQCA-BSA(或OVA)抗原 | 3796 |
| 双酚A-BSA(或OVA)抗原 | 3705 |
| 大观霉素-BSA(或OVA)抗原 | 3753 |
| 磺胺对甲氧嘧啶(SMD)-BSA(或OVA)抗原 | 3763 |
| 磺胺间甲氧嘧啶-BSA(或OVA)抗原 | 3883 |
| 磺胺噻唑-BSA(或OVA)抗原 | 3904 |
| 磺胺甲基嘧啶-BSA(或OVA)抗原 | 3681 |
| 磺胺异恶唑-BSA(或OVA)抗原 | 3698 |
| 磺胺嘧啶(SD)-BSA(或OVA)抗原 | 3870 |
| 磺胺喹恶啉-BSA(或OVA)抗原 | 3740 |
| 磺胺二甲嘧啶(SM2)-BSA(或OVA)抗原 | 3783 |
| 磺胺甲恶唑-BSA(或OVA)抗原 | 3935 |
| 磺胺类(Sas)-BSA(或OVA)抗原 | 3870 |